Haleon plc (LON:HLN)
389.90
+8.00 (2.09%)
Mar 28, 2025, 5:08 PM BST
Haleon Revenue
In the year 2024, Haleon had annual revenue of 11.23B GBP, down -0.61%. Haleon had revenue of 2.76B in the quarter ending December 31, 2024, a decrease of -0.25%.
Revenue
11.23B
Revenue Growth
-0.61%
P/S Ratio
3.17
Revenue / Employee
457.35K
Employees
25,408
Market Cap
35.23B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
Oxford Nanopore Technologies | 183.19M |
Haleon News
- 4 days ago - Haleon: A Defensive Play That Makes Sense Amidst The Stock Market Sell-Off - Seeking Alpha
- 9 days ago - Sensodyne toothpaste maker Haleon now an independent company after Pfizer sells stake - This is Money
- 10 days ago - Pfizer exits Haleon stake after $3.2B share sale - Seeking Alpha
- 10 days ago - Pfizer offloads final shares in Sensodyne maker Haleon - Evening Standard
- 10 days ago - Pfizer Sells Remaining Stake in Haleon for $3.25 Billion - GuruFocus
- 10 days ago - Pfizer sells entire Haleon stake for $3.24 billion - Reuters
- 10 days ago - FTSE 100 Live 19 March: Index steady after US selling, Pfizer makes £2.5bn Haleon exit - Evening Standard
- 10 days ago - Pfizer to sell remaining stake in Haleon - Seeking Alpha